Gladstone NOW: The Campaign Join Us on the Journey✕
Michael Alexanian is studying two promising genetic avenues for addressing heart failure, a massive global health burden in need of innovative treatments.
Alexanian Lab Cardiovascular Disease Human Genetics Grants Congenital Heart DiseaseBruneau, director of the Gladstone Institute of Cardiovascular Disease, will receive the association’s highest scientific honor in November.
News Release Congenital Heart Disease Cardiovascular Disease AwardsGladstone researchers found losing just one copy a particular gene can disrupt heart development and lead to congenital heart disease.
News Release Bruneau Lab Pollard Lab Cardiovascular Disease Data Science and Biotechnology Congenital Heart Disease Stem Cells/iPSCs